{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:32:27Z","timestamp":1773383547417,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/aci.0b013e32836097f4","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T22:02:03Z","timestamp":1363989723000},"page":"263-267","source":"Crossref","is-referenced-by-count":31,"title":["Glucocorticosteroids for the treatment and prevention of anaphylaxis"],"prefix":"10.1097","volume":"13","author":[{"given":"Aziz","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2044.2012.07159.x","article-title":"Anaphylaxis admissions to UK critical care units between 2005 and 2009.","volume":"67","author":"Gibbison","year":"2012","journal-title":"Anaesthesia"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaci.2011.01.038","article-title":"World Allergy Organization guidelines: summary.","volume":"127","author":"Simons","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ACI.0b013e328355b7e4","article-title":"2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis.","volume":"12","author":"Simons","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/all.12012","article-title":"Anaphylaxis in an emergency setting: elicitors, therapy and incidence of severe allergic reactions.","volume":"67","author":"Beyer","year":"2012","journal-title":"Allergy"},{"key":"R5-8-20210128","first-page":"746","article-title":"Randomised controlled trials in primary care: scope and application.","volume":"52","author":"Sheikh","year":"2002","journal-title":"Br J Gen Pract"},{"key":"R7-8-20210128","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1398-9995.2007.01433.x","article-title":"Evidence-based management of anaphylaxis.","volume":"62","author":"Simons","year":"2007","journal-title":"Allergy"},{"key":"R8-8-20210128","first-page":"384","article-title":"Pharmacologic treatment of anaphylaxis: can the evidence base be strengthened Curr Opin Allergy Clin I","volume":"10","author":"Simons","year":"2010","journal-title":"mmunol"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1398-9995.2012.02829.x","article-title":"Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10.","volume":"67","author":"Tanno","year":"2012","journal-title":"Allergy"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions.","volume":"30","author":"Pumphrey","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/joe.0.1690065","article-title":"Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"169","author":"Charmandari","year":"2001","journal-title":"J Endocrinol"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1398-9995.2007.01434.x","article-title":"Comparison of international guidelines for the emergency medical management of anaphylaxis.","volume":"62","author":"Alrasbi","year":"2007","journal-title":"Allergy"},{"key":"R13-8-20210128","first-page":"CD007596","article-title":"Glucocorticoids for the treatment of anaphylaxis.","volume":"3","author":"Choo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-8-20210128","first-page":"CD007596","article-title":"Glucocorticoids for the treatment of anaphylaxis.","volume":"4","author":"Choo","year":"2012","journal-title":"Cochrane Database Syst Review"},{"key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/bmj.38905.634132.AE","article-title":"Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review.","volume":"333","author":"Tramer","year":"2006","journal-title":"Br Med J"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/11592050-000000000-00000","article-title":"Effect of premedication on early adverse reactions following antivenom use in snakebite: a systematic review and meta-analysis.","volume":"34","author":"Habib","year":"2011","journal-title":"Drug Saf"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"e1000435","DOI":"10.1371\/journal.pmed.1000435","article-title":"Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial.","volume":"8","author":"de Silva","year":"2011","journal-title":"PLoS Med"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.iac.2011.02.002","article-title":"Immunotherapy: the meta-analyses.","volume":"31","author":"Calderon","year":"2011","journal-title":"What have we learned Immunol Allergy Clin North Am"},{"key":"R19-8-20210128","first-page":"CD007685","article-title":"Sublingual immunotherapy for treating allergic conjunctivitis.","volume":"6","author":"Calderon","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-8-20210128","first-page":"CD001186","article-title":"Injection allergen immunotherapy for asthma.","volume":"8","author":"Abramson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-8-20210128","first-page":"CD009014","article-title":"Allergen-specific oral immunotherapy for peanut allergy.","volume":"9","author":"Nurmatov","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4104\/pcrj.2011.00071","article-title":"Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies.","volume":"21","author":"Sheikh","year":"2012","journal-title":"Prim Care Respir J"},{"key":"R23-8-20210128","first-page":"CD008838","article-title":"Venom immunotherapy for preventing allergic reactions to insect stings.","volume":"17","author":"Boyle","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-8-20210128","first-page":"409","article-title":"Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts.","volume":"73","author":"Portnoy","year":"1994","journal-title":"Ann Allergy"},{"key":"R25-8-20210128","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1067\/mai.2002.121956","article-title":"Safety and efficacy of an imported fire ant rush immunotherapy protocol with and without prophylactic treatment.","volume":"109","author":"Tankersley","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"R26-8-20210128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-7022-2-20","article-title":"EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.","volume":"2","author":"Calderon","year":"2012","journal-title":"Clin Transl Allergy"},{"key":"R27-8-20210128","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.","volume":"364","author":"Busse","year":"2011","journal-title":"N Engl J Med"},{"key":"R28-8-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ACI.0b013e32835bf3f5","article-title":"Omalizumab and hypersensitivity reactions.","volume":"13","author":"Shankar","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R29-8-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/CCRPM.S7793","article-title":"Omalizumab: clinical use for the management of asthma.","volume":"6","author":"Thomson","year":"2012","journal-title":"Clin Med Insights Circ Respir Pulm Med"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e32836097f4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:51:40Z","timestamp":1636563100000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201306000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e32836097f4","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}